ICU Medical Inc IC7
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €140.00
- Day Range
- €139.00–142.00
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 25.01M
- Market Cap
- $3.55B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 20.01
- Price/Sales
- 1.92
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 13,000
- Website
- https://www.icumed.com
Competitors
Valuation
|
Metric
|
IC7
|
BAX
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.01 | 11.94 | 14.13 |
Price/Book Value | 1.88 | 2.03 | 2.05 |
Price/Sales | 1.92 | 1.09 | 2.59 |
Price/Cash Flow | 12.09 | 11.33 | 13.87 |
Price/Earnings
IC7
BAX
BDX
Financial Strength
|
Metric
|
IC7
|
BAX
|
BDX
|
|---|---|---|---|
Quick Ratio | 1.04 | 1.12 | 0.36 |
Current Ratio | 2.43 | 1.95 | 0.94 |
Interest Coverage | 0.89 | −0.81 | 3.53 |
Quick Ratio
IC7
BAX
BDX
Profitability
|
Metric
|
IC7
|
BAX
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 3.28% | 4.99% | 4.97% |
Return on Equity (Normalized) | 6.24% | 15.42% | 10.63% |
Return on Invested Capital (Normalized) | 5.49% | 7.44% | 7.26% |
Return on Assets
IC7
BAX
BDX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|tRBvy<R | LOCK|g?d | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|t>h | LOCK|S!&gm | $50B | |||
| ResMed Inc
RMD
| LOCK|ZH$!?Y> | LOCK|X>>j^ | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|xr<#$@ | LOCK|M%$g | $32B | |||
| Alcon Inc
ALC
| LOCK|K@Px>& | LOCK|&ZJ<# | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|!G<K>fNf | LOCK|^@& | $26B | |||
| Solventum Corp
SOLV
| LOCK|?!^$KH | LOCK|tkJ | $15B | |||
| Baxter International Inc
BAX
| LOCK|<&& | LOCK|?@$#V | $13B | |||
| Repligen Corp
RGEN
| LOCK|qddnxPv& | LOCK|n%%? | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|sQxh!<N | LOCK|^Fggl | $10B |
United States